Risk factors for deterioration of nodular bronchiectatic Mycobacterium avium complex lung disease

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 6, 2014, Pages

  Kim, S J ^a   Park, J ^a   Lee, H ^a   Lee, Y J ^a   Park, J S ^a   Cho, Y J ^a   Yoon, H I ^a   Lee, C T ^a   Lee, J H ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Bronchiectasis; M. avium complex; Nutrition; Risk factors; Subcutaneous fat

Indexed keywords

ADULT; ARTICLE; BODY MASS; BRONCHIECTASIS; CHEST COMPUTERISED TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; COUGHING; DETERIORATION; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DYSPNEA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; FORCED VITAL CAPACITY; HUMAN; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; LUNG; LUNG FUNCTION TEST; LUNG SEGMENT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM COMPLEX DISEASE; MYCOBACTERIUM INTRACELLULARE AVIUM; NODULAR BRONCHIECTASIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT DISEASE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SPUTUM EXAMINATION; SUBCUTANEOUS FAT; SYMPTOMATOLOGY; THICKNESS; AGED; COMPLICATION; DISEASE COURSE; FORCED EXPIRATORY VOLUME; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RADIOGRAPHY; REGISTER; SPIROMETRY; SPUTUM; TIME; VITAL CAPACITY;

AGED; BACTERIOLOGICAL TECHNIQUES; BODY MASS INDEX; BRONCHIECTASIS; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; NUTRITIONAL STATUS; PREDICTIVE VALUE OF TESTS; REGISTRIES; RISK FACTORS; SPIROMETRY; SPUTUM; SUBCUTANEOUS FAT; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY;

EID: 84901282820     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0792     Document Type: Article

References (30)

1. Ikegame S, Maki S, Wakamatsu K, et al. Nutritional assessment in patients with pulmonary non-tuberculous mycobacteriosis. Intern Med 2011; 50: 2541-2546.
2. Adjemian J, Olivier K N, Seitz A E, Holland S M, Prevots D R. Prevalence of non-tuberculous mycobacterial lung disease in US Medicare beneficiaries. Am J Respir Crit Care Med 2012; 185: 881-886.
3. Lai C C, Tan C K, Chou C H, et al. Increasing incidence of non-tuberculous mycobacteria, Taiwan, 2000-2008. Emerg Infect Dis 2010; 16: 294-296.
4. Andrejak C, Thomsen V O, Johansen I S, et al. Non-tuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med 2010; 181: 514-521.
5. Yoo J W, Jo K W, Kim M N, et al. Increasing trend of isolation of non-tuberculous mycobacteria in a tertiary university hospital in South Korea. Tuberc Respir Dis (Seoul) 2012; 72: 409-415.
6. Prevots D R, Shaw P A, Strickland D, et al. Non-tuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010; 182: 970-976.
7. Moore J E, Kruijshaar M E, Ormerod L P, Drobniewski F, Abubakar I. Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006. BMC Public Health 2010; 10: 612.
8. Park Y S, Lee C H, Lee S M, et al. Rapid increase of non-tuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea. Int J Tuberc Lung Dis 2010; 14: 1069-1071.
9. Dirac M A, Horan K L, Doody D R, et al. Environment or host?: a case-control study of risk factors for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2012; 186: 684-691.
10. Griffith D E, Aksamit T, Brown-Elliott B A, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
11. Griffith D E, Aksamit T R. Bronchiectasis and non-tuberculous mycobacterial disease. Clin Chest Med 2012; 33: 283-295.
12. de Mello K G, Mello F C, Borga L, et al. Clinical and therapeutic features of pulmonary non-tuberculous mycobacterial disease, Brazil, 1993-2011. Emerg Infect Dis 2013; 19: 393-399.
13. Daley C L, Griffith D E. Pulmonary non-tuberculous mycobacterial infections. Int J Tuberc Lung Dis 2010; 14: 665-671.
14. Hartman T E, Swensen S J, Williams D E. Mycobacterium avium- intracellulare complex: evaluation with CT. Radiology 1993; 187: 23-26. (Pubitemid 23097852)
15. Schluger N W. Treatment of pulmonary Mycobacterium avium complex infections: do drug levels matter? Am J Respir Crit Care Med 2012; 186: 710-711.
16. Koh W J, Jeong B H, Jeon K, Lee S Y, Shin S J. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2012; 186: 797-802.
17. Lam P K, Griffith D E, Aksamit T R, et al. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006; 173: 1283-1289. (Pubitemid 43848401)
18. Kobashi Y, Matsushima T, Oka M. A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease. Respir Med 2007; 101: 130-138. (Pubitemid 44835234)
19. Koh W J, Jeong B H, Jeon K, et al. Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M. avium complex lung disease. Chest 2012; 142: 1482-1488.
20. Field S K, Fisher D, Cowie R L. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest 2004; 126: 566-581. (Pubitemid 39093445)
21. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-1136.
22. Kubo K, Yamazaki Y, Hachiya T, et al. Mycobacterium avium-intracellulare pulmonary infection in patients without known predisposing lung disease. Lung 1998; 176: 381-391. (Pubitemid 28559322)
23. Yamazaki Y, Kubo K, Takamizawa A, Yamamoto H, Honda T, Sone S. Markers indicating deterioration of pulmonary Mycobacterium avium- intracellulare infection. Am J Respir Crit Care Med 1999; 160: 1851-1855. (Pubitemid 30004686)
24. Prince D S, Peterson D D, Steiner R M, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989; 321: 863-868. (Pubitemid 19238618)
25. Narayanan V, Gaudiani J L, Mehler P S. Serum albumin levels may not correlate with weight status in severe anorexia nervosa. Eat Disord 2009; 17: 322-326.
26. Kim R D, Greenberg D E, Ehrmantraut M E, et al. Pulmonary non-tuberculous mycobacterial disease: prospective study of a distinct pre-existing syndrome. Am J Respir Crit Care Med 2008; 178: 1066-1074.
27. Mehta M, Marras T K. Impaired health-related quality of life in pulmonary non-tuberculous mycobacterial disease. Respir Med 2011; 105: 1718-1725.
28. Lee M R, Yang C Y, Chang K P, et al. Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease. PLOS ONE 2013; 8: e58214.
29. Okumura M, Iwai K, Ogata H, et al. Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease. Intern Med 2008; 47: 1465-1472.
30. Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2012; 185: 575-583.